Sfoglia per AUTORE
PORTA C
Collezione AOU Novara

  

Items : 21

Lower Expression of SARS-CoV-2 Host Cell Entry Genes in the Intestinal Mucosa of IBD Patients With Quiescent or Mildly Active Disease. in Inflammatory bowel diseases / Inflamm Bowel Dis. 2025 Apr 25:izaf079. doi: 10.1093/ibd/izaf079.
2025
AOU Novara

Pisani LF; Albertini Petroni G; Crespi G; Mola S; Annunziata ML; Caprioli FA; Porta C; Pastorelli L;

2024
AOU Novara

Santoni M; Buti S; Myint ZW; Maruzzo M; Iacovelli R; Pichler M; Kopecky J; Kucharz J; Rizzo M; Galli L; Büttner T; De Giorgi U; Kanesvaran R; Fiala O; Grande E; Zucali PA; Kopp RM; Fornarini G; Bourlon MT; Scagliarini S; Molina-Cerrillo J; Aurilio G; Matrana MR; Pichler R; Cattrini C; Büchler T; Massari F; Seront E; Calabrò F; et alii...

Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study. in Cancer immunology, immunotherapy : CII / Cancer Immunol Immunother. 2024 Apr 18;73(6):106. doi: 10.1007/s00262-024-03682-w.
2024
ASL Cuneo 2
AOU Novara

Mosca A; Morelli F; Bisonni R; Bamias A; Santini D; Herchhorn D; Kanesvaran R; Inman E; Caitano M; Messina C; Martignetti A; Kopecky J; Milella M; Procopio G; Abahssain H; Roviello G; Kopp RM; Bassanelli M; Fernandez M; Cutuli HJ; Grillone F; Aceituno LG; Seront E; de Carvalho Fernandes R; Nogueira L; Mennitto A; Dauster B; Monteiro FSM; Barillas A; et alii...

Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1). in Clinical genitourinary cancer / Clin Genitourin Cancer. 2023 Oct;21(5):e309-e319.e1. doi: 10.1016/j.clgc.2023.03.006. Epub 2023 Mar
2023
AOU Novara

Santoni M; Massari F; Myint ZW; Iacovelli R; Pichler M; Basso U; Kopecky J; Kucharz J; Buti S; Salfi A; Büttner T; De Giorgi U; Kanesvaran R; Fiala O; Grande E; Zucali PA; Fornarini G; Bourlon MT; Scagliarini S; Molina-Cerrillo J; Aurilio G; Matrana MR; Pichler R; Cattrini C; Büchler T; Seront E; Calabrò F; Pinto A; Berardi R; et alii...

Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study. in Cancer immunology, immunotherapy : CII / Cancer Immunol Immunother. 2023 Nov;72(11):3665-3682. doi: 10.1007/s00262-023-03518-z. Epub 2023 Sep
2023
AOU Novara

Fiala O; Buti S; Takeshita H; Okada Y; Massari F; Palacios GA; Dionese M; Scagliarini S; Büttner T; Fornarini G; Myint ZW; Galli L; Souza VC; Pichler R; De Giorgi U; Quiroga MNG; Gilbert D; Popovic L; Grande E; Mammone G; Berardi R; Crabb SJ; Molina-Cerrillo J; Freitas M; Luz M; Iacovelli R; Calabrò F; Tural D; Atzori F; et alii...

Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study. in Targeted oncology / Target Oncol. 2023 Jul;18(4):559-570. doi: 10.1007/s11523-023-00978-2. Epub 2023 Jun 27.
2023
AOU Novara

Santoni M; Massari F; Myint ZW; Iacovelli R; Pichler M; Basso U; Kopecky J; Kucharz J; Buti S; Rizzo M; Galli L; Büttner T; De Giorgi U; Kanesvaran R; Fiala O; Grande E; Zucali PA; Fornarini G; Bourlon MT; Scagliarini S; Molina-Cerrillo J; Aurilio G; Matrana MR; Pichler R; Cattrini C; Büchler T; Seront E; Calabrò F; Pinto A; et alii...

Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations. in Minerva urology and nephrology / Minerva Urol Nephrol. 2023 Aug;75(4):460-470. doi: 10.23736/S2724-6051.23.05369-7.
2023
AOU Novara

Porta C; Bamias A; Zakopoulou R; Myint ZW; Cavasin N; Iacovelli R; Pichler M; Kopecky J; Kucharz J; Rizzo M; Galli L; Büttner T; DE Giorgi U; Kanesvaran R; Fiala O; Grande E; Zucali PA; Kopp RM; Fornarini G; Bourlon MT; Scagliarini S; Molina-Cerrillo J; Aurilio G; Matrana MR; Pichler R; Cattrini C; Büchler T; Massari F; Mollica V; et alii...

2022
ASL Asti
AOU Novara

Fassan M; Sbaraglia M; Galuppini F; Aberasturi Plata Y; Zito-Marino F; Franco R; Rizzo M; Massari F; Cossarizza A; Bollito E; Salvioni R; Conti G; Lapini A; Colombo P; Patriarca C; Pierconti F; Basso U; Maruzzo M; Munari E; Atzori F; Montagnani I; Gobbo S; Umari P; Mosca A; Iacovelli R; Pappagallo G; Alongi F; Eccher A; Ortega C; et alii...

Repeat partial nephrectomy for recurrence of Von Hippel-Lindau-related renal cell carcinoma in an autotransplanted kidney. in Urology case reports / Urol Case Rep. 2020 Dec 28;35:101553. doi: 10.1016/j.eucr.2020.101553. eCollection 2021 Mar.
2021
AOU Novara

Volpe A; Maso G; Porta C; Bondonno G; Marchioro G; Perri D;

GU-CA-COVID: a clinical audit among Italian genitourinary oncologists during the first COVID-19 outbreak. in Therapeutic advances in urology / Ther Adv Urol. 2021 Oct 22;13:17562872211054302. doi: 10.1177/17562872211054302. eCollection 2021 Ja
2021
AOU Novara

Bersanelli M; Buti S; Rizzo M; Cortellini A; Cattrini C; Massari F; Masini C; Vitale MG; Fornarini G; Caffo O; Atzori F; Gatti A; Macrini S; Mucciarini C; Galli L; Morelli F; Stellato M; Fanelli M; Corti F; Zucali PA; Toscani I; Dalla Volta A; Gernone A; Baldessari C; La Torre L; Zara D; Gennari A; Bracarda S; Procopio G; et alii...

2021
AOU Città della Salute di Torino
AOU Novara

Tassi R; Guideri F; Mannino M; Lochner P; Monaco S; Del Sette M; Schirinzi E; Risitano A; Toni D; Volodina V; Doronin B; Palmerini F; Saggese CE; Dawson J; Abdul-Rahim AH; Aridon P; Terruso V; Arnao V; Gasparro A; Marcheselli S; Reale G; Zauli A; Caliandro P; Masotti L; Grifoni E; Frontera JA; Yaghi S; Scher E; Rigatelli A; et alii...

Toward a genome-based treatment landscape for renal cell carcinoma. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2019 Oct;142:141-152. doi: 10.1016/j.critrevonc.2019.07.020. Epub 2019 Aug 2
2019
AOU Novara

Massari F; Di Nunno V; Santoni M; Gatto L; Caserta C; Morelli F; Zafarana E; Carrozza F; Mosca A; Mollica V; Iacovelli R; Sabbatini R; Porta C; Bracarda S;

Targeting angiogenesis in metastatic renal cell carcinoma. in Expert review of anticancer therapy / Expert Rev Anticancer Ther. 2019 Mar;19(3):245-257. doi: 10.1080/14737140.2019.1574574. Epub 2019 Fe
2019
AOU Novara

Canino C; Perrone L; Bosco E; Saltalamacchia G; Mosca A; Rizzo M; Porta C;

Effect of Cyclic Stretch on Vascular Endothelial Cells and Abdominal Aortic Aneurysm (AAA): Role in the Inflammatory Response. in International journal of molecular sciences / Int J Mol Sci. 2019 Jan 12;20(2):287. doi: 10.3390/ijms20020287.
2019
AOU Novara

Ramella M; Bertozzi G; Fusaro L; Talmon M; Manfredi M; Catoria MC; Casella F; Porta CM; Boldorini R; Fresu LG; Marengo E; Boccafoschi F;

Endovascular repair of popliteal artery aneurysms: an Italian multicenter study. in La Radiologia medica / Radiol Med. 2019 Jan;124(1):79-85. doi: 10.1007/s11547-018-0941-0. Epub 2018 Sep 19.
2019
AOU Novara

Guzzardi G; Natrella M; Del Sette B; Petullà M; Fanelli G; Porta C; Carriero A; Laganà D;

Kidney transplantation in patients with previous renal cancer: a critical appraisal of current evidence and guidelines. in Journal of nephrology / J Nephrol. 2019 Feb;32(1):57-64. doi: 10.1007/s40620-018-0542-y. Epub 2018 Oct 16.
2019
AOU Novara

Frascà GM; Brigante F; Volpe A; Cosmai L; Gallieni M; Porta C;

Relevance of inflammation and matrix remodeling in abdominal aortic aneurysm (AAA) and popliteal artery aneurysm (PAA) progression. in American journal of translational research / Am J Transl Res. 2018 Oct 15;10(10):3265-3275. eCollection 2018.
2018
AOU Novara

Ramella M; Bernardi P; Fusaro L; Manfredi M; Casella F; Porta CM; Nicolai L; Galeazzi E; Boldorini R; Settembrini AM; Settembrini P; Marengo E; Cannas M; Boccafoschi F;

Endothelial MMP-9 drives the inflammatory response in abdominal aortic aneurysm (AAA). in American journal of translational research / Am J Transl Res. 2017 Dec 15;9(12):5485-5495. eCollection 2017.
2017
AOU Novara

Ramella M; Boccafoschi F; Bellofatto K; Follenzi A; Fusaro L; Boldorini R; Casella F; Porta C; Settembrini P; Cannas M;

Sunitinib, pazopanib or sorafenib for the treatment of patients with late relapsing metastatic renal cell carcinoma. in The Journal of urology / J Urol. 2015 Jan;193(1):41-7. doi: 10.1016/j.juro.2014.07.011. Epub 2014 Jul 18.
2015
AOU Novara

Santoni M; Conti A; Porta C; Procopio G; Sternberg CN; Basso U; De Giorgi U; Bracarda S; Rizzo M; Ortega C; Massari F; Iacovelli R; Derosa L; Masini C; Milella M; Di Lorenzo G; Atzori F; Pagano M; Buti S; De Vivo R; Mosca A; Rossi M; Paglino C; Verzoni E; Cerbone L; Muzzonigro G; Falconi M; Montironi R; Burattini L; et alii...

Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project†. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2015 Dec;26(12):2392-8. doi: 10.1093/annonc/mdv380. Epub 2015 Sep 14.
2015
AOU Novara

Kramar A; Negrier S; Sylvester R; Joniau S; Mulders P; Powles T; Bex A; Bonnetain F; Bossi A; Bracarda S; Bukowski R; Catto J; Choueiri TK; Crabb S; Eisen T; El Demery M; Fitzpatrick J; Flamand V; Goebell PJ; Gravis G; Houédé N; Jacqmin D; Kaplan R; Malavaud B; Massard C; Melichar B; Mourey L; Nathan P; Pasquier D; et alii...

Targeting PI3K/Akt/mTOR Signaling in Cancer. in Frontiers in oncology / Front Oncol. 2014 Apr 14;4:64. doi: 10.3389/fonc.2014.00064. eCollection 2014.
2014
AOU Novara

Porta C; Paglino C; Mosca A;

©2024 Tutti i diritti riservati. Biblioteca Virtuale per la Salute - Piemonte